drugset / Trial / NCT02169271

Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules

NCT02169271

Phase 2 Completed 109 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupDouble-blindPrevention

Summary

This randomized phase II trial studies acetylsalicylic acid compared to placebo in treating high-risk patients with subsolid lung nodules. A nodule is a growth or lump that may be malignant (cancer) or benign (not cancer). Chemoprevention is the use of drugs to keep cancer from forming or coming back. The use of acetylsalicylic acid may keep cancer from forming in patients with subsolid lung nodules.

Timeline

Start
2014-11-21
Primary completion
2018-07-13
Completion
2020-02-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule Oral

Indications